Clinical Trial Update: Assessment the Diagnostic Value of Pro-Neurotensin as a Serum Biomarker in MASLD

View source ↗

Summary

Clinical trial evaluating whether serum pro-neurotensin can serve as a diagnostic biomarker for metabolic dysfunction-associated steatotic liver disease (MASLD)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatotic Liver Disease
• Steatosis of the Liver

Snippet

Sponsor: Sohag University | Conditions: Steatosis of Liver | Status: NOT_YET_RECRUITING